biopharm: whoahhh! I think the platform is moving forward in approximate relationship to its worth, but I've said for some long time that if Bavi- is as good as we think it is, who on earth needs a partner? We still don't know how good it is, similar to a game of 5 card stud with scrambled top cards and an unknown in the hole. We'll see. Meanwhile PPHM is providing some seminal research for the public and big pharma for a most nominal price tag.